Loading…
Johnson & Johnson is projected to rise to $319.33 by 2027, a +24% move from its current price of $256.98. JNJ is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $253.26 | $257.07 | $260.93 | +0.03% |
| Jul 14 | $251.78 | $257.15 | $262.64 | +0.07% |
| Jul 15 | $250.68 | $257.24 | $263.97 | +0.10% |
| Jul 16 | $249.76 | $257.33 | $265.12 | +0.13% |
| Jul 17 | $248.97 | $257.41 | $266.14 | +0.17% |
| Jul 18 | $248.26 | $257.50 | $267.08 | +0.20% |
| Jul 19 | $247.62 | $257.59 | $267.96 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $247.62 | $257.59 | $267.96 | +0.24% |
| Week 2 | $244.18 | $258.19 | $273.02 | +0.47% |
| Week 3 | $241.70 | $258.80 | $277.12 | +0.71% |
| Week 4 | $239.73 | $259.42 | $280.72 | +0.95% |
| Week 5 | $238.06 | $260.03 | $284.02 | +1.19% |
| Week 6 | $236.62 | $260.64 | $287.10 | +1.43% |
| Week 7 | $235.35 | $261.26 | $290.01 | +1.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Johnson & Johnson is a global healthcare company engaged in research and development, manufacturing, and sale of a wide range of products. It operates in two segments, Innovative Medicine and MedTech, serving prescription, surgical, orthopedic, cardiovascular, and vision-related needs worldwide. The Innovative Medicine segment covers therapies across oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular/metabolism, distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
The MedTech segment provides products and enabling technologies for joint reconstruction, trauma, spine, sports injuries, and other procedures, along with breast aesthetics and reconstruction, contact lenses under ACUVUE, intraocular lenses under TECNIS, and other cataract/refractive products.
The company was founded in 1886 and is based in New Brunswick, New Jersey. This long-standing healthcare institution combines a broad product portfolio with a global footprint across patient care settings and professional medical channels.
Johnson & Johnson launched on January 1, 1886.
Johnson & Johnson (JNJ) is currently priced at $254.66, with a market capitalization of $613.02B and a ranking of 19. The 30-day technical picture shows bullish potential, supported by a bullish overall sentiment and a solid technical setup. The forecast path indicates a strong long-term upside, with the average price climbing well beyond today’s level across multiple years.
For 2026, the forecast implies an average price of $254.66 with a range from $204.31 to $335.05, and an ROI of 0%. Beyond 2026, the model projects a rising trajectory, with 2030 averaging $487.61 and a max of $665.11, yielding a 91.5% ROI and a bullish sentiment, continuing through 2050 with an average near $2,262.85 and a max of $3,700.83, underscoring a persistent bullish outlook.
These figures reflect price projections and should be viewed as estimates rather than guarantees. The asset’s current price and market standing provide a foundation for the forecasted long-term price path, which remains contingent on future market conditions.
A major floor 20.3% below — a decisive break under it would weaken the trend.
The nearest floor, 13.3% below — buyers have tended to step in here.
The nearest ceiling, 4.0% above — a clean break opens room to run.
A major ceiling 14.2% above — clearing it would confirm fresh momentum.
Key JNJ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of JNJ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $261.21 | Sell | $259.39 | Sell |
| MA 10 | $259.02 | Sell | $256.71 | Buy |
| MA 20 | $247.95 | Buy | $250.38 | Buy |
| MA 50 | $236.11 | Buy | $241.46 | Buy |
| MA 100 | $237.82 | Buy | $234.65 | Buy |
| MA 200 | $221.07 | Buy | $221.05 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.76 | Neutral |
| Stoch RSI (14) | 42.29 | Neutral |
| CCI (20) | 54.37 | Neutral |
| Williams %R (14) | -28.54 | Info |
| MACD (12,26,9) | 0.90 | Buy |
| ROC (12) | 7.49 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 71.46 | Neutral |
| TRIX (15) | 0.42 | Buy |
| Awesome (5,34) | 20.59 | Buy |
| Ultimate (7,14,28) | 61.26 | Neutral |
| Momentum (10) | 12.10 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 262.12 | Sell |
| ADX (14) | 26.19 | Buy |
| ATR (14) | 3.85 | Info |
The near-term technical picture is bullish, with RSI(14) at 60 indicating room for upside momentum. The price remains above key moving averages, with the SMA50 at $230.34 and the SMA200 at $216.95, suggesting an incumbent uptrend.
In the near term, traders should note a defined support at $222.89 and a resistance level at $244.88. The 30-day trading range spans from $234.76 to $276.25, placing today’s price of $254.66 within that window.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $204.31 | $256.98 | $340.17 | 0% | Neutral | |
| $261.53 | $319.33 | $407.63 | +24% | Bullish | |
| $305.23 | $379.68 | $497.78 | +48% | Bullish | |
| $366.70 | $463.18 | $620.19 | +80% | Bullish | |
| $392.84 | $502.91 | $685.51 | +96% | Bullish | |
| $417.09 | $540.48 | $748.37 | +110% | Bullish | |
| $453.99 | $594.93 | $835.49 | +132% | Bullish | |
| $467.29 | $618.81 | $880.28 | +141% | Bullish | |
| $563.13 | $753.14 | $1,084.17 | +193% | Bullish | |
| $658.86 | $889.52 | $1,294.75 | +246% | Bullish | |
| $873.12 | $1,229.48 | $1,875.40 | +378% | Bullish | |
| $1,638.17 | $2,473.99 | $4,045.17 | +863% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $204.31 | $256.98 | $306.83 | +0.00% |
| August 2026 | $227.05 | $265.76 | $317.79 | +3.42% |
| September 2026 | $225.31 | $265.00 | $319.36 | -0.29% |
| October 2026 | $223.76 | $264.25 | $320.57 | -0.28% |
| November 2026 | $229.52 | $271.99 | $331.79 | +2.93% |
| December 2026 | $233.37 | $277.46 | $340.17 | +2.01% |
Click any year to see its month-by-month JNJ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Johnson & Johnson's 2026 outlook centres on $256.98, within a $204.31 to $340.17 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, JNJ could reach as high as $407.63, with a base case around $319.33 and support toward $261.53 — roughly +24% from $256.98. Momentum favours further upside here.
Expect JNJ to range from $305.23 to $497.78 through 2028. The $379.68 average target implies a +48% move from current prices. That is up +19% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The JNJ price prediction for 2029 points to an average of $463.18 (low $366.70, high $620.19) — a potential gain of +80% on today's $256.98. Momentum favours further upside here.
In 2030, JNJ is projected to trade between $392.84 and $685.51, averaging $502.91 — a potential gain of +96% from today's $256.98. That is up +9% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Johnson & Johnson's 2031 outlook centres on $540.48, within a $417.09 to $748.37 range. That is up +7% on the projected 2030 average. That marks a +110% change versus current levels. Momentum favours further upside here.
By 2032, JNJ could reach as high as $835.49, with a base case around $594.93 and support toward $453.99 — roughly +132% from $256.98. Buyers look set to stay in control over this stretch.
Expect JNJ to range from $467.29 to $880.28 through 2033. The $618.81 average target implies a +141% move from current prices. That is up +4% on the projected 2032 average. Momentum favours further upside here.
The JNJ price prediction for 2034 points to an average of $753.14 (low $563.13, high $1,084.17) — a potential gain of +193% on today's $256.98. Buyers look set to stay in control over this stretch.
In 2035, JNJ is projected to trade between $658.86 and $1,294.75, averaging $889.52 — a potential gain of +246% from today's $256.98. That is up +18% on the projected 2034 average. Momentum favours further upside here.
Johnson & Johnson's 2040 outlook centres on $1,229.48, within a $873.12 to $1,875.40 range. That is up +38% on the projected 2035 average. That marks a +378% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, JNJ could reach as high as $4,045.17, with a base case around $2,473.99 and support toward $1,638.17 — roughly +863% from $256.98. Momentum favours further upside here.
Investing $1,000 in JNJ today (≈ 3.891353 JNJ) could be worth
$9,627.19
+$8,627.19 (+863%) by 2050 · US Dollar
Based on the average projected JNJ price of $2,473.99 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in JNJwould be worth at today's price.
$1,000 invested in JNJ on Jul 10, 2025 (≈ 6.341556 JNJ) would be worth
$1,629.65
+$629.65 (+63.0%) today · 1.63× · US Dollar
Based on a JNJ entry price of $157.69 vs. today's $256.98.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $263.04 | $976.96 | -2.3% |
| 1 month ago | $238.49 | $1,077.53 | +7.8% |
| 3 months ago | $238.46 | $1,077.66 | +7.8% |
| 6 months ago | $209.72 | $1,225.35 | +22.5% |
| 1 year ago | $157.69 | $1,629.65 | +63.0% |
| All time (5.0y) ago | $169.27 | $1,518.17 | +51.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our JNJ forecast.
Our base-case forecast reaches $510.00 around 2031.
Implied market cap at $510.00: $1.23T
The multi-year outlook remains broadly bullish across the forecast horizon, with steady earnings-like growth implied by rising average prices and sizable ROIs. In 2027 the average price is projected at $313.61 with a 23.1% ROI, followed by 2028 at $374.61 (47.1% ROI) and 2029 at $446.99 (75.5% ROI).
By 2030, the average is forecast at $487.61 with a 91.5% ROI, and sentiment labeled bullish. The 2040 projection shows an average of $1,158.86 with a 355.1% ROI, while 2050 is estimated at an average of $2,262.85 and a max of $3,700.83, delivering a projected ROI of 788.6% and a bullish stance.
These are estimates, not guarantees, and they reflect the long-run bullish trajectory implied by the provided forecast figures. Investors should consider the potential for volatility and uncertainty over extended horizons while noting the strong upward path suggested by the data.
Tap a question to reveal the answer.
2030's forecast shows an average price of $487.61 with a min of $380.69 and a max of $665.11, and a 91.5% ROI; sentiment is BULLISH.
The forecast displays a bullish trajectory from 2027 onward, with rising averages and positive ROIs (e.g., 2027 avg $313.61, 23.1% ROI; 2028 avg $374.61, 47.1% ROI; 2029 avg $446.99, 75.5% ROI; 2030 avg $487.61, 91.5% ROI), though 2026 is neutral.
Yes, per the forecast, the 2040 max is $1,768.28 and the 2050 max is $3,700.83, indicating that crossing $1,000 is within the projected ranges (2030 avg is $487.61).
Current price is $254.66 and market capitalization is $613.02B.
RSI(14) is 60, SMA50 is $230.34, SMA200 is $216.95. The stock has support at $222.89 and resistance at $244.88. The 30-day range is $234.76 to $276.25; the sentiment is BULLISH.
Johnson & Johnson Community Discussion
0Share your Johnson & Johnson price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.